The imipridone ONC201 (also known as TRAIL-inducing-compound 10, TIC10) was discovered in an attempt to identify drugs that are capable of inducing TRAIL, which was once considered as a potential “holy grail” of anti-cancer therapy [33]. This evidence concerns the gene TNFSF10 and cancer.